Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Aluminium adjuvants, typically referred to as 'alum', are the most commonly used adjuvants in human and animal vaccines worldwide, yet the mechanism underlying the stimulation of the immune system by alum remains unknown. Toll-like receptors are critical in sensing infections and are therefore common targets of various adjuvants used in immunological studies. Although alum is known to induce the production of proinflammatory cytokines in vitro, it has been repeatedly demonstrated that alum does not require intact Toll-like receptor signalling to activate the immune system. Here we show that aluminium adjuvants activate an intracellular innate immune response system called the Nalp3 (also known as cryopyrin, CIAS1 or NLRP3) inflammasome. Production of the pro-inflammatory cytokines interleukin-1beta and interleukin-18 by macrophages in response to alum in vitro required intact inflammasome signalling. Furthermore, in vivo, mice deficient in Nalp3, ASC (apoptosis-associated speck-like protein containing a caspase recruitment domain) or caspase-1 failed to mount a significant antibody response to an antigen administered with aluminium adjuvants, whereas the response to complete Freund's adjuvant remained intact. We identify the Nalp3 inflammasome as a crucial element in the adjuvant effect of aluminium adjuvants; in addition, we show that the innate inflammasome pathway can direct a humoral adaptive immune response. This is likely to affect how we design effective, but safe, adjuvants in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Cryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Recognition of microorganisms and activation of the immune response
Medzhitov, R. (2007) · Nature · doi:10.1038/nature06246 · Cited by 2,862
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,041
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02664 · Cited by 1,839
Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Molecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684
Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration
Pétrilli, V, Papin, S., Dostert, C., Mayor, A., Martinon, F., & Tschopp, J. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402195 · Cited by 1,445
Kool, M., Soullié, T., van Nimwegen, M., Willart, M. A. M., Muskens, F., Jung, S., Hoogsteden, H. C., Hammad, H., & Lambrecht, B. N. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071087 · Cited by 993
Cited by
Items 701–800 of 1,002
Fang, H., Shao, S., Cao, T., Lei, J., Dang, E., Zhang, J., & Wang, G. (2016) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2016.04.009 · Cited by 38
Li, X., Shenashen, M. A., Wang, X., Ito, A., Taniguchi, A., & El‐Safty, S. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-12446-9 · Cited by 42
MicroRNA‑33 regulates the NLRP3 inflammasome signaling pathway in macrophages
Xie, Q., Meng, W., Zhang, B., Kang, X., Liu, D., Zheng, W., Pan, X., Quan, Y., Liao, D., & Shen, J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8224 · Cited by 39
Cationic lipids as one-component vaccine adjuvants: A promising alternative to alum
Pizzuto, M., Bigey, P., Lachagès, A.-M., Hoffmann, C., Ruysschaert, J., Escriou, V., & Lonez, C. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.020 · Cited by 40
Inflammasomes as Targets for Adjuvants
Ivanov, K., Garanina, E. E., Rizvanov, A. A., & Khaiboullina, S. F. (2020) · Pathogens · doi:10.3390/pathogens9040252 · Cited by 40
“IL-1β and IL-18 by activating NLRP3 inflammasome [58,59].”
BackgroundChen, L., Hou, W., Liu, F., Zhu, R., Lv, A., Quan, W., & Mao, S. (2022) · Journal of Immunology Research · doi:10.1155/2022/9444227 · Cited by 42
“Mice with allergic asthma induced by OVA and aluminium adjuvants demonstrated enhanced protein expression of NLRP3 and caspase-1, along with elevated IL1β and IL-18 release by epithelial cells and macrophages in the airways [17].”
BackgroundPharmacology and therapeutic potential of pattern recognition receptors
Paul‐Clark, M. J., George, P. M., Gatheral, T. L., Parzych, K., Wright, W. R., Crawford, D., Bailey, L. K., Reed, D. M., & Mitchell, J. A. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.05.007 · Cited by 45
Church, L. D., Savic, S., & McDermott, M. (2008) · Biologics · doi:10.2147/btt.s3167 · Cited by 43
“Monosodium urate (Martinon et al 2006), calcium pyrophosphate and silica crystals (Cassel et al 2008), alumin-ium hydroxide (a vaccine adjuvant) (Eisenbarth et al 2008), DNA fragments (Muruve et al 2008), ATP and potassium fl ux (Petrilli et al 2007) have all so far been identifi ed as danger signals…”
Systemic immunotoxicity reactions induced by adjuvanted vaccines
Batista-Duharte, A., Portuondo, D. L., Pérez, O., & Carlos, I. Z. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.02.033 · Cited by 41
Robays, L. J., Lanckacker, E. A., Moerloose, K., Maes, T., Bracke, K. R., Brusselle, G., Joos, G., & Vermaelen, K. Y. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802204 · Cited by 48
“Furthermore, alum, a prototypical Th2-skewing adjuvant, was shown to exert its adjuvant effect in a TLR4-independent way and to activate the NLRP3 inflammasome pathway either directly or through the release of uric acid from the local tissue microenvironment (58, 59).”
BackgroundUse and limitations of alum‐based models of allergy
Eisenbarth, S. C. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.03069.x · Cited by 40
Self-citationEffector functions of NLRs in the intestine: innate sensing, cell death, and disease
Yeretssian, G. (2012) · Immunologic Research · doi:10.1007/s12026-012-8317-3 · Cited by 37
A Rational, Systematic Approach for the Development of Vaccine Formulations
Morefield, G. L. (2011) · The AAPS Journal · doi:10.1208/s12248-011-9261-1 · Cited by 37
Microglia in Neurodegenerative Events—An Initiator or a Significant Other?
Harry, G. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115818 · Cited by 40
“These sterile activators, or “triggers”, include cholesterol crystals [81] and uric acid crystals [82,83], aggregated proteins and lipids [84,85], silica and asbestos [86], aluminum salt adjuvant [87], polystyrene nanoparticles [88], and triorganotin compounds [89].”
BackgroundNanoalum adjuvanted vaccines: small details make a big difference
Raponi, A., Brewer, J. M., Garside, P., & Laera, D. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101544 · Cited by 40
Chen, J., Wang, M.-X., Wang, M., Zhang, Y.-K., Guo, X., Chen, Y., Zhang, M.-Q., Sun, J., Liu, Y., & Liu, C. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114379 · Cited by 40
Particulate inorganic adjuvants: recent developments and future outlook
Maughan, C. N., Preston, S. G., & Williams, G. R. (2015) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12352 · Cited by 41
“Eisenbarth et al.([98]) Imject-Alum Yes Li et al.”
BackgroundType I IFN-mediated regulation of IL-1 production in inflammatory disorders
Ludigs, K., Parfenov, V., Pasquier, R. D., & Guarda, G. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0989-2 · Cited by 41
Innate sensors of influenza virus: clues to developing better intranasal vaccines
Ichinohe, T., Iwasaki, A., & Hasegawa, H. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.9.1435 · Cited by 42
“Since the Th2-inducing activity of the most commonly used adjuvant, alum [127], is mediated through inflammasome activation [128], inflammasome activation may prove to be important in vaccine designs in the future.”
BackgroundT Cell Costimulation by TNFR Superfamily (TNFRSF)4 and TNFRSF25 in the Context of Vaccination
Schreiber, T. H., Wolf, D., Bodero, M. D., Gonzalez, L. E., & Podack, E. R. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200597 · Cited by 37
Pattern recognition receptors of innate immunity and their application to tumor immunotherapy
Seya, T., Shime, H., Ebihara, T., Oshiumi, H., & Matsumoto, M. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2009.01442.x · Cited by 42
Inflammasomes in Pneumococcal Infection: Innate Immune Sensing and Bacterial Evasion Strategies
Rabes, A., Suttorp, N., & Opitz, B. (2016) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-41171-2_11 · Cited by 41
Petterson, T., Månsson, A., Riesbeck, K., & Cardell, L. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03414.x · Cited by 38
Redirecting soluble antigen for MHC class I cross‐presentation during phagocytosis
Hari, A., Ganguly, A., Mu, L., Davis, S. P., Stenner, M. D., Lam, R., Munro, F., Namet, I., Alghamdi, E., Fürstenhaupt, T., et al. (2014) · European Journal of Immunology · doi:10.1002/eji.201445156 · Cited by 40
Malaria Vaccine Adjuvants: Latest Update and Challenges in Preclinical and Clinical Research
Mata, E., Salvador, A., Igartúa, M., Hernández, R. M., & Pedraz, J. L. (2013) · BioMed Research International · doi:10.1155/2013/282913 · Cited by 43
“This activation leads to caspase-1 activation, proinflammatory cytokine secretion (IL-1β, IL-18, IL-33), andmonocytemigration to lymph nodes (LNs) for their differentiation into inflammatory dendritic cells (DCs) [17, 18].”
BackgroundHair Trace Elements in Overweight and Obese Adults in Association with Metabolic Parameters
Геннадиевна, С. М., Skalny, A. V., Grabeklis, A. R., Serebryansky, E. P., Demidov, V. A., & Tinkov, A. A. (2018) · Biological Trace Element Research · doi:10.1007/s12011-018-1282-5 · Cited by 39
Innate sensors that regulate vaccine responses
Georg, P., & Sander, L. E. (2019) · Current Opinion in Immunology · doi:10.1016/j.coi.2019.02.006 · Cited by 39
AKT controls NLRP3 inflammasome activation by inducing DDX3X phosphorylation
Guo, X., Chen, S., Yu, W., Chi, Z., Wang, Z., Xu, T., Zhang, J., Jiang, D., Guo, Y., Fang, H., et al. (2021) · FEBS Letters · doi:10.1002/1873-3468.14175 · Cited by 36
Chen, L., Xu, M., Wang, Z., Chen, B., Du, W., Su, C., Shen, X., Zhao, A.-H., Dong, N., Wang, Y., et al. (2010) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2010.00660.x · Cited by 36
“…1 activation in vivo, which is mediated by nucleotide-binding domain and leucine-rich repeat-containing gene (NLR) family, pyrin domaincontaining 3 (NLRP3) and apoptosis-associated speck-like protein containing a CARD (ASC), collectively known as the nlrp3 inflammasome (Eisenbarth et al., 2008).”
BackgroundOptimizing vaccine development
Hoft, D. F., Brusić, V., & Sakala, I. G. (2011) · Cellular Microbiology · doi:10.1111/j.1462-5822.2011.01609.x · Cited by 36
“Until very recently, the only adjuvants approved for human use were aluminium salts, which can increase the half-life of an antigen, improve uptake by professional phagocytes and trigger the inflammasome via NALP3 sensing (Eisenbarth et al., 2008).”
BackgroundWeilhammer, D. R., Blanchette, C., Fischer, N. O., Alam, S., Loots, G. G., Corzett, M., Thomas, C. B., Lychak, C., Dunkle, A. D., Ruitenberg, J. J., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.038 · Cited by 38
Airway epithelial regulation of allergic sensitization in asthma
Poynter, M. E. (2012) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2012.04.005 · Cited by 36
“response to antigen sensitization using an Alum-containing adjuvant [132], whereas Kool et al.”
MethodChen, J., Ni, G., & Liu, X. S. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.03.003 · Cited by 35
Recent exploration of bio-mimetic nanomaterial for potential biomedical applications
Prianka, T. R., Subhan, N., Reza, H. M., Hosain, M. K., Rahman, M. A., Lee, H., & Sharker, S. M. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.09.012 · Cited by 35
Acidic Mammalian Chitinase Is Not a Critical Target for Allergic Airway Disease
Fitz, L. J., DeClercq, C., Brooks, J., Kuang, W., Bates, B., Demers, D. A., Winkler, A. R., Nocka, K. H., Jiao, A., Greco, R. M., et al. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0095oc · Cited by 35
Mann, C. J., Anguela, X. M., Montané, J., Obach, M., Roca, C., Ruzo, A., Otaegui, P. J., Mir, L. M., & Bosch, F. (2011) · Gene Therapy · doi:10.1038/gt.2011.198 · Cited by 35
Ckless, K., Hodgkins, S. R., Ather, J. L., Martin, R., & Poynter, M. E. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.03.005 · Cited by 41
“Understanding the biochemical events involved in NLRP3 activation is applicable to– allergic asthma because Alum, the best-studied adjuvant used to promote Th2 responses, functions–in part through its capacity to activate the NLRP3 inflammasome (113, 129).”
BackgroundAllergy Is a Protective Factor Against Age-Related Macular Degeneration
Ristau, T., Ersoy, L., Lechanteur, Y. T. E., den Hollander, A. I., Daha, M. R., Hahn, M., Hoyng, C. B., & Fauser, S. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13248 · Cited by 43
Kooijman, S., Brummelman, J., van Els, C. A. C. M., Marino, F., Heck, A. J. R., Mommen, G. P. M., Metz, B., Kersten, G. F. A., Pennings, J. L. A., & Meiring, H. D. (2018) · Journal of Proteomics · doi:10.1016/j.jprot.2017.12.021 · Cited by 36
“Besides this, uric acid can also activate the inflammasome in vitro [15, 21].”
BackgroundGamma delta T cells recognize haptens and mount a hapten-specific response
Zeng, X., Meyer, C., Huang, J., Newell, E. W., Kidd, B. A., Wei, Y.-L., & Chien, Y. (2014) · eLife · doi:10.7554/elife.03609 · Cited by 40
“Alum was used because it is a non-antigenic adjuvant (Eisenbarth et al., 2008), and we chose subcutaneous immunization because it focuses the immune response to the draining lymph nodes.”
Promising Adjuvants and Platforms for Influenza Vaccine Development
Zhu, W., Dong, C., Wei, L., & Wang, B. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13010068 · Cited by 37
“Studies have suggested that Alum functions in several ways, such as helping with antigen uptake [8], the induction of interleukin-1ß release by inflammasomes [9], enhancing antigen presentation, and strengthening the interaction between dendritic cells (DCs) and CD4+ T cells [10].”
BackgroundAirway responses towards allergens – from the airway epithelium to T cells
Papazian, D., Hansen, S., & Würtzen, P. A. (2015) · Clinical & Experimental Allergy · doi:10.1111/cea.12451 · Cited by 38
Pouliot, K., Buglione‐Corbett, R., Marty-Roix, R., Paquette, S. W. M., West, K., Wang, S., Lu, S., & Lien, E. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.07.010 · Cited by 34
Aluminium based adjuvants and their effects on mitochondria and lysosomes of phagocytosing cells
Ohlsson, L., Exley, C., Darabi, A., Sandén, E., Siesjö, P., & Eriksson, H. (2013) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2013.08.003 · Cited by 39
Le Bert, N., Chain, B. M., Rook, G., & Noursadeghi, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018346 · Cited by 34
“In addition, the inflammasome has been reported to augment rather than inhibit Th2 responses [48].”
BackgroundRobays, L. J., Maes, T., Joos, G. F., & Vermaelen, K. Y. (2009) · Mucosal Immunology · doi:10.1038/mi.2009.7 · Cited by 41
Immunology of Vaccine Adjuvants
Ribeiro, C. M. S., & Schijns, V. E. C. J. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-585-9_1 · Cited by 43
Chen, G., Severo, M. S., Sakhon, O. S., Choy, A., Herron, M. J., Felsheim, R. F., Wiryawan, H., Liao, J., Johns, J. L., Munderloh, U. G., et al. (2012) · Infection and Immunity · doi:10.1128/iai.00532-12 · Cited by 36
Self-citationExploiting vita-PAMPs in vaccines
Blander, J. M., & Barbet, G. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.05.012 · Cited by 36
“including dependence of the potent humoral response elicited by aluminum-containing (alum) adjuvants on NLRP3 inflammasome activation [51,52], the enhancement of antibody production through IL-1 administration during immunization [53–55], and the significant”
Developmental Immunology and Role of Host Defenses in Fetal and Neonatal Susceptibility to Infection
Lewis, D. B., & Wilson, C. B. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6400-8.00004-3 · Cited by 42
Neutrophils and extracellular traps in crystal-associated diseases
Ma, Q., & Steiger, S. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.05.010 · Cited by 35
Adjuvant effect of zinc oxide on Th2 but not Th1 immune responses in mice
Matsumura, M., Nagata, M., Nakamura, K., Kawai, M., Baba, T., Yamaki, K., & Yoshino, S. (2009) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923970903124627 · Cited by 33
Gartlan, K. H., Krashias, G., Wegmann, F., Hillson, W. R., Scherer, E. M., Greenberg, P. D., Eisenbarth, S. C., Moghaddam, A. E., & Sattentau, Q. J. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.03.025 · Cited by 34
“immune system via defined pathways, including those triggered by toll-like receptors (TLRs) [1,2], the NLRP3 inflammasome [3,4] and IRF3 [5,6].”
BackgroundSelf-citationAggregation and Dissociation of Aqueous Al13 Induced by Fluoride Substitution
Wang, X., Zhang, G., Fu, X., Hu, C., Liu, R., Liu, H., Xu, X., & Qu, J. (2017) · Environmental Science & Technology · doi:10.1021/acs.est.6b05876 · Cited by 33
Ferko, M.-A., & Catelas, I. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199936 · Cited by 35
Cationic Nanostructures for Vaccines Design
Carmona‐Ribeiro, A. M., & Pérez-Betancourt, Y. (2020) · Biomimetics · doi:10.3390/biomimetics5030032 · Cited by 35
“Aluminum adjuvants typically activate the inflammasome pathway and Th 2 response [72] so that alum combinations with TLR agonists are needed to induce the cell-mediated Th 1 response against pathogens [5].”
BackgroundMeng, F., Wang, J., He, Y., Cresswell, G. M., Lanman, N. A., Lyle, L. T., Ratliff, T. L., & Yeo, Y. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2122595119 · Cited by 34
Glycans as Vaccine Antigens and Adjuvants: Immunological Considerations
Zimmermann, S., & Lepenies, B. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2874-3_2 · Cited by 36
Vaccine adjuvants – understanding molecular mechanisms to improve vaccines
Egli, A., Santer, D. M., Barakat, K., Zand, M. S., Levin, A., Vollmer, M., Weisser, M., Khanna, N., Kumar, D., Tyrrell, D. L., et al. (2014) · Swiss Medical Weekly · doi:10.4414/smw.2014.13940 · Cited by 34
Mucosal vaccine development for respiratory viral infections
Lin, Y., Hu, Z., Fu, Y., & Peng, H. (2023) · hLife · doi:10.1016/j.hlife.2023.12.005 · Cited by 35
“Potent adju-vants, such as incomplete Freund ’ s adjuvant (IFA), MPL. CpG, etc., function by inducing the production of various cytokines, including type I interferons (IFNs), IFN-g , IL-2, IL-12, and IL-18 [134,135].”
Dasgupta, P., Chapoval, S. P., Smith, E., & Keegan, A. D. (2011) · BMC Immunology · doi:10.1186/1471-2172-12-60 · Cited by 32
“These cytokines play important roles in initiation and amplification of TH2 responses including TH2 cell proliferation and eosinophilia [52,53].”
BackgroundQuercetin exhibits adjuvant activity by enhancing Th2 immune response in ovalbumin immunized mice
Singh, D. K., Tanwar, H., Jayashankar, B., Sharma, J., Murthy, S., Chanda, S., Singh, S. B., & Ganju, L. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.03.067 · Cited by 32
Risk of gout flares after vaccination: a prospective case cross-over study
Yokose, C., McCormick, N., Chen, C. A., Neogi, T., Chaisson, C. E., Terkeltaub, R. A., Hunter, D. J., Zhang, Y., & Choi, H. K. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215724 · Cited by 33
Massa, D., Baran, M., Bengoechea, J. A., & Bowie, A. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011400 · Cited by 33
“Overall human PYHINs seem to function remarkably similar to the nuclear oligomerization domain (NOD) family of proteins in that some are inflammasome activators (AIM2 and NOD NLRP3) (18, 62), some are PRRs (IFI16 and NOD NOD1) (9, 63), and some are transcriptional regulators (PYHIN-1 and NODs NLRP12 and CIITA) (64, 65…”
BackgroundSynergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine
Mai, J., Li, Z., Xia, X., Zhang, J., Li, J., Liu, H., Shen, J., Ramirez, M., Li, F., Li, Z., et al. (2021) · Advanced Science · doi:10.1002/advs.202100166 · Cited by 36
Lutz, E. A., Agarwal, Y., Momin, N., Cowles, S. C., Palmeri, J. R., Duong, E., Hornet, V., Sheen, A. M., Lax, B. M., Rothschilds, A. M., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2205983119 · Cited by 34
Inflammasome activation and metabolic disease progression
Li, H., Jin, C., Chen, Y., & Flavell, R. A. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.020 · Cited by 35
Self-citationOkamoto, S., Yoshii, H., Matsuura, M., Kojima, A., Ishikawa, T., Akagi, T., Akashi, M., Takahashi, M., Yamanishi, K., & Mori, Y. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05412-11 · Cited by 32
“However, it still unclear whether the Nlrp3inflammasome is dispensable for alum’s adjuvant activity (7, 9).”
BackgroundGPRC6A mediates Alum-induced Nlrp3 inflammasome activation but limits Th2 type antibody responses
Quandt, D., Rothe, K., Baerwald, C., & Rossol, M. (2015) · Scientific Reports · doi:10.1038/srep16719 · Cited by 38
“IL-1 β is processed by the inflammasome and it was previously reported that Alum adjuvanticity depends on the inflammasome 6,7 .”
Mitochondria–Endoplasmic Reticulum Contact Sites Mediate Innate Immune Responses
Misawa, T., Takahama, M., & Saitoh, T. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-4567-7_14 · Cited by 35
Shi, W., Kou, Y., Xiao, J., Zhang, L., Gao, F., Kong, W., Su, W., Jiang, C., & Zhang, Y. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.07.006 · Cited by 33
Ma, Q., & Lim, C. S. (2023) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-031023-125300 · Cited by 41
Pal, S., Chaudhari, R., Baurceanu, I., Hill, B. J., Nagy, B. A., & Wolf, M. T. (2024) · Advanced Materials · doi:10.1002/adma.202309843 · Cited by 33
Kelkka, T., Hultqvist, M. H., Nandakumar, K. S., & Holmdahl, R. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.03.031 · Cited by 35
“Similarly, alum, a NALP3 inflammasome activator, 37 did not enhance antibody-induced joint inflammation.”
BackgroundBourquin, C., Wurzenberger, C., Heidegger, S., Fuchs, S., Anz, D., Weigel, S., Sandholzer, N., Winter, G., Coester, C., & Endres, S. (2010) · Journal of immunotherapy · doi:10.1097/cji.0b013e3181f5dfa7 · Cited by 33
“Indeed, particulate adjuvants such as alum, poly(lactide-co-glycolyde), and polystyrene microparticles enhance TLR-induced secretion of proinflammatory cytokines by dendritic cells through stimulation of the NALP3 (NACHT-, LRP-containing and PYD-containing protein 3) inflammasome receptor complex.(32,33) It is thus po…”
BackgroundAluminum and Neurodegenerative Diseases
Bondy, S. C., & Campbell, A. (2017) · Advances in neurotoxicology · doi:10.1016/bs.ant.2017.07.008 · Cited by 40
“Aluminum salts, used as adjuvants in vaccines, cause necrosis and uric acid production which functions as a danger signal to activate the NLRP3 inflammasome (Eisenbarth et al., 2008).”
BackgroundRecent advances in the development of vaccines for chronic inflammatory autoimmune diseases
Zhang, N., & Nandakumar, K. S. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.04.062 · Cited by 32
Reyes, C., & Patarroyo, M. A. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175632 · Cited by 34
Abdel-Mageed, A. M., Isobe, N., & Yoshimura, Y. (2014) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2014.10.013 · Cited by 34
“The mucosal tissues of the uterus and vagina contain many cell types including macrophages which may produce proinflammatory cytokines (Eisenbarth et al., 2008).”
BackgroundShakya, A. K., Kumar, A., & Nandakumar, K. S. (2011) · Journal of The Royal Society Interface · doi:10.1098/rsif.2011.0114 · Cited by 31
Duong, K. M., Arikkatt, J., Ullah, M. A., Lynch, J. P., Zhang, V., Atkinson, K., Sly, P. D., & Phipps, S. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0431oc · Cited by 32
Evolution of Adjuvants Across the Centuries
Garçon, N., & Friede, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00006-7 · Cited by 38
Yao, H. H., Zhang, Y., Liu, L., Xu, Y., Liu, X., Lin, J., Zhou, W., Wei, P., Jin, P., & Wen, L. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.08.036 · Cited by 31
Takagi, M., Takakubo, Y., Pajarinen, J., Naganuma, Y., Oki, H., Maruyama, M., & Goodman, S. B. (2017) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2017.05.004 · Cited by 35
Cholesterol Crystal-Mediated Inflammation Is Driven by Plasma Membrane Destabilization
Shu, F., Chen, J., Ma, X., Fan, Y., Yu, L., Zheng, W., Amrein, M., Xia, T., & Shi, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01163 · Cited by 34
Neutrophils negatively regulate induction of mucosal IgA responses after sublingual immunization
Jee, J., Bonnegarde-Bernard, A., Duverger, A. E., Iwakura, Y., Cormet‐Boyaka, E., Martin, T. L., Steiner, H. E., Bachman, R. C., & Boyaka, P. N. (2015) · Mucosal Immunology · doi:10.1038/mi.2014.105 · Cited by 32
Kufer, T. A., Nigro, G., & Sansonetti, P. J. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0021-2015 · Cited by 34
“Interestingly, the commonly used clinical adjuvant alum triggers the activation of the NLRP3 in fl ammasome (36 – 38).”
USP3 deubiquitinates and stabilizes the adapter protein ASC to regulate inflammasome activation
Zhuang, W., Zhang, L., Zheng, Y., Liu, B., Ma, C., Zhao, W., Liu, S., Liu, F., & Gao, C. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00917-7 · Cited by 31
“Then, we employed a model of peritonitis induced by the NLRP3 inflammasome activator Alum, a widely used adjuvant that promotes leukocyte recruitment via the induction of NLRP3 inflammasome-dependent IL-1β secretion [27, 28].”
MethodTerhune, T. D., & Deth, R. C. (2012) · Journal of Immunotoxicology · doi:10.3109/1547691x.2012.708366 · Cited by 30
“Recent studies indicate that the immune response to aluminum adjuvants involves the nucleotide-binding domain/leucine-rich-repeat-containing gene family pyrin-domain-containing-3 (NLRP3; also known as NALP3) inflammasome activation of caspase-1 and the release of IL-1β, IL-18, and IL-33 (Li et al., 2007, 2008; Sokolov…”
BackgroundInfluentialDavis, M. J., & Swanson, J. A. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0310159 · Cited by 35
“Three naturally occurring danger signals— monosodium-urate crystals [11], extracellular ATP [12, 13], and plasma membrane perforation [12, 13], as well as particulate asbestos [14], -amyloids [15], silica [14, 16, 17], and alum [17, 18]—activate the NLRP3 inflammasome.”
BackgroundPizzolla, A., Smith, J. M., Brööks, A. G., & Reading, P. C. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.4mr0716-290r · Cited by 32
“Alum leads to disruption of lysosomes and, therefore, cellular stress, providing signal 2 for inflammasome activation, with consequent production of IL-1b and IL-18 [110].”
BackgroundInfluentialNaito, Y., Hamaoka, S., Kinoshita, M., Kainuma, A., Shimizu, M., Katoh, H., Moriyama, K., Ishii, K. J., & Sawa, T. (2018) · Microbiology and Immunology · doi:10.1111/1348-0421.12658 · Cited by 30
Autoinflammatory syndromes for the dermatologist
Dávila‐Seijo, P., Hernández‐Martín, A., & Torrelo, A. (2014) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2014.02.004 · Cited by 29
Barilaro, G., Testa, C. S., Cacciani, A., Donato, G., Dimko, M., & Mariotti, A. (2016) · Immunologic Research · doi:10.1007/s12026-016-8871-1 · Cited by 33
“Adjuvants may act in several ways: by increasing the local reactions in the site of injection by mimicking danger signals [6–8]; by inducing a progressive release of the antigen, hindering its clearance and enabling a longer exposure of the antigen to antigen-presenting cells; by promoting the translocation of antigen…”
BackgroundNeunkirchner, A., Kratzer, B., Köhler, C., Smole, U., Mager, L. F., Schmetterer, K. G., Trapin, D., Reichl, V., Rosloniec, E. F., Naumann, R., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.04.001 · Cited by 30
“Moreover, it iswell known that adjuvants, such as the frequently used Al(OH)3, apart from activating the inflammasome in a NRLP3-dependent manner (Eisenbarth et al., 2008) also lead to structural rearrangements in co-administered proteins that not only deviate the immune response to different components found in aller…”
BackgroundDistinctive cellular response to aluminum based adjuvants
Nies, I., Hidalgo, K., Bondy, S. C., & Campbell, A. (2020) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2020.103404 · Cited by 30
“Aluminum adjuvants have been shown to cause cellular necrosis and the subsequent production of uric acid, which acts as a threat signal, functions to activate the Nlrp3 inflammasome (Eisenbarth et al., 2008).”
BackgroundKim, E., Attia, Z., Woodfint, R. M., Zeng, C., Kim, S. H., Steiner, H. E., Shukla, R. K., Liyanage, N. P. M., Ghimire, S., Lǐ, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2102435118 · Cited by 31
“Alum stimulates IL-1 β secretion, which activates myeloid cells, including Gr1 + cells (4 – 8 , 10).”
Nickle-cobalt alloy nanocrystals inhibit activation of inflammasomes
Lin, J., Dong, L., Liu, Y., Hu, Y., Jiang, C., Liu, K., Liu, L., Song, Y., Sun, M., Xiang, X.-C., et al. (2023) · National Science Review · doi:10.1093/nsr/nwad179 · Cited by 32
“The cytolytic P-2Z receptor for extracellular ATP identified as a P-2X receptor (P2X(7)).”
BackgroundOma, K., Zhao, J., Ezoe, H., Akeda, Y., Koyama, S., Ishii, K. J., Kataoka, K., & Oishi, K. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.055 · Cited by 33
Mortellaro, A., & Ricciardi‐Castagnoli, P. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2010.152 · Cited by 34
Metadata
- Authors
- Eisenbarth, S. C., Colegio, O. R., O’Connor, W., Sutterwala, F. S., & Flavell, R. A.
- Affiliations
- Yale University (US)
- University of Iowa (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Flavell, Richard A.
- Venue
- Nature
- Published
- 2008-05-21
- Volume
- 453
- Issue
- 7198
- Pages
- 1122-1126
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4804622
- OpenAlex
- W1979991507
- Cited by
- 1,542
- References
- 45
- Citations by year
- 2026: 34 · 2025: 43 · 2024: 54 · 2023: 56 · 2022: 52 · 2021: 81 · 2020: 62 · 2019: 53 · 2018: 74 · 2017: 81 · 2016: 91 · 2015: 85 · 2014: 91 · 2013: 125 · 2012: 132
- FWCI
- 57.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Bill and Melinda Gates Foundation
- National Institutes of Health
- National Heart, Lung, and Blood Institute (T32HL007974)
- National Institute of Allergy and Infectious Diseases (K08AI065517)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32AR007016)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- NLRP3 inflammasome, aluminum hydroxide adjuvant, vaccine adjuvants, innate immunity, macrophages, IL-1β, IL-18, caspase-1, ASC, humoral antibody response, adaptive immune response, Toll-like receptors, complete Freund's adjuvant
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Adjuvants, Immunologic, Alum Compounds, Animals, Antibodies, Carrier Proteins, Cytoskeletal Proteins, Enzyme Activation, T-Lymphocytes, Helper-Inducer, Immunity, Innate, Inflammation, Macrophages, Mice, Inbred C57BL, Potassium, Cell Death, Caspase 1, Interleukin-18, Apoptosis Regulatory Proteins, Mice, CARD Signaling Adaptor Proteins, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.